SUSE Future Growth
Future criteria checks 4/6
SUSE is forecast to grow earnings and revenue by 117.7% and 7.4% per annum respectively. EPS is expected to grow by 117.7% per annum. Return on equity is forecast to be 7.2% in 3 years.
Key information
117.7%
Earnings growth rate
117.7%
EPS growth rate
| Software earnings growth | 39.6% |
| Revenue growth rate | 7.4% |
| Future return on equity | 7.2% |
| Analyst coverage | Low |
| Last updated | 15 Nov 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 10/31/2025 | 794 | 187 | N/A | N/A | 2 |
| 10/31/2024 | 730 | 25 | N/A | N/A | 2 |
| 10/31/2023 | 684 | N/A | N/A | N/A | 2 |
| 7/31/2023 | 673 | -40 | 124 | 146 | N/A |
| 4/30/2023 | 670 | -39 | 140 | 158 | N/A |
| 1/31/2023 | 668 | -20 | 163 | 179 | N/A |
| 10/31/2022 | 653 | -39 | 133 | 147 | N/A |
| 7/31/2022 | 635 | -77 | 124 | 142 | N/A |
| 4/30/2022 | 613 | -94 | -14 | 2 | N/A |
| 1/31/2022 | 587 | -197 | 2 | 16 | N/A |
| 10/31/2021 | 560 | -208 | -12 | 3 | N/A |
| 7/31/2021 | 528 | -199 | -23 | -17 | N/A |
| 4/30/2021 | 491 | -155 | 80 | 90 | N/A |
| 1/31/2021 | 472 | -52 | 92 | 105 | N/A |
| 10/31/2020 | 447 | -52 | 93 | 129 | N/A |
| 10/31/2019 | 296 | -97 | 40 | 46 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SUSE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.5%).
Earnings vs Market: SUSE is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SUSE is expected to become profitable in the next 3 years.
Revenue vs Market: SUSE's revenue (7.4% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: SUSE's revenue (7.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SUSE's Return on Equity is forecast to be low in 3 years time (7.2%).